Literature DB >> 9463740

The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors.

G T Ko1, J C Chan, J Woo, E Lau, V T Yeung, C C Chow, C S Cockram.   

Abstract

We examined the reproducibility of oral glucose tolerance tests (OGTT) using the World Health Organization criterion in 212 Chinese subjects (male 149, female 63) who underwent two 75 g OGTTs within a 6-week period. The overall reproducibility was 65.6% (139/212) of which 74 subjects had normal glucose tolerance, 24 had diabetes and 41 had impaired glucose tolerance (IGT) on two occasions. The subjects were divided into three groups [group 1: normal OGTTs on both occasions (n = 74); group 2: one abnormal OGTT (either diabetes or IGT (n = 51); group 3: 2 abnormal OGTTs (n = 87)]. Subjects in group 1 were younger, had lower blood pressure, body mass index (BMI), waist-to-hip ratio (WHR), fasting and 2 h plasma insulin levels, triglyceride, very-low density lipoprotein and apolipoprotein-B concentrations than both groups 2 and 3. Group 2 had similar characteristics as group 3 except for a lower glycated haemoglobin (HbA1c), fasting and 2 h plasma glucose during the two OGTTs. With receiver operating characteristic curve (ROC) analysis, a HbA1c of 5.3% gave an optimal sensitivity of 70.7% and specificity of 74.3% to predict diabetes as defined by a 2 h plasma glucose value > or = 11.1 mmol/L in the first OGTT. Of the 212 subjects, 73 had HbA1c > or = 5.3%. The reproducibility of OGTT was 56.2% for these 73 subjects. With ROC analysis, a BMI of 25 kg/m2 gave an optimal sensitivity of 53.7% and specificity of 56.7% to predict diabetes. For the 36 subjects with BMI > or = 25 kg/m2, the reproducibility of OGTT was 58.3%. Similarly, for the 140 subjects with WHR > or = 0.9, the reproducibility of OGTT was 57.9%. These findings confirmed the poor reproducibility of OGTT which was not improved even amongst subjects with high HbA1c, BMI or WHR. Furthermore, subjects with one abnormal OGTT, whether reproducible or not, had a higher cardiovascular risk profile compared to subjects who had two normal OGTTs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9463740     DOI: 10.1177/000456329803500107

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  43 in total

Review 1.  The impact of new guidelines for glucose tolerance testing on clinical practice and laboratory services.

Authors:  Andrew W Lyon; Erik T Larsen; Alun L Edwards
Journal:  CMAJ       Date:  2004-10-26       Impact factor: 8.262

2.  Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women.

Authors:  Aruna D Pradhan; Nader Rifai; Julie E Buring; Paul M Ridker
Journal:  Am J Med       Date:  2007-08       Impact factor: 4.965

Review 3.  Best practice in primary care pathology: review 10.

Authors:  W S A Smellie; N Shaw; R Bowley; M F Stewart; A M Kelly; P J Twomey; P R Chadwick; J B Houghton; J P Ng; A J McCulloch
Journal:  J Clin Pathol       Date:  2007-05-11       Impact factor: 3.411

4.  Restorative yoga and metabolic risk factors: the Practicing Restorative Yoga vs. Stretching for the Metabolic Syndrome (PRYSMS) randomized trial.

Authors:  Alka M Kanaya; Maria Rosario G Araneta; Sarah B Pawlowsky; Elizabeth Barrett-Connor; Deborah Grady; Eric Vittinghoff; Michael Schembri; Ann Chang; Mary Lou Carrion-Petersen; Traci Coggins; Daniah Tanori; Jean M Armas; Roger J Cole
Journal:  J Diabetes Complications       Date:  2013-12-10       Impact factor: 2.852

Review 5.  HbA1c for screening and diagnosis of diabetes mellitus.

Authors:  Trefor Higgins
Journal:  Endocrine       Date:  2012-08-21       Impact factor: 3.633

6.  DISTq: An Iterative Analysis of Glucose Data for Low-Cost, Real-Time and Accurate Estimation of Insulin Sensitivity.

Authors:  Paul D Docherty; J Geoffrey Chase; Thomas Lotz; Christopher E Hann; Geoffrey M Shaw; Juliet E Berkeley; J I Mann; Kirsten McAuley
Journal:  Open Med Inform J       Date:  2009-12-02

7.  Incidence of type 2 diabetes using proposed HbA1c diagnostic criteria in the european prospective investigation of cancer-norfolk cohort: implications for preventive strategies.

Authors:  Parinya Chamnan; Rebecca K Simmons; Nita G Forouhi; Robert N Luben; Kay-Tee Khaw; Nicholas J Wareham; Simon J Griffin
Journal:  Diabetes Care       Date:  2010-07-09       Impact factor: 19.112

8.  Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects.

Authors:  Dag Hofsø; Trond Jenssen; Helle Hager; Jo Røislien; Jøran Hjelmesaeth
Journal:  Obes Surg       Date:  2009-12-01       Impact factor: 4.129

9.  Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients.

Authors:  Eva C Knudsen; Ingebjørg Seljeflot; Michael Abdelnoor; Jan Eritsland; Arild Mangschau; Harald Arnesen; Geir O Andersen
Journal:  Cardiovasc Diabetol       Date:  2009-01-30       Impact factor: 9.951

10.  Corra: Computational framework and tools for LC-MS discovery and targeted mass spectrometry-based proteomics.

Authors:  Mi-Youn Brusniak; Bernd Bodenmiller; David Campbell; Kelly Cooke; James Eddes; Andrew Garbutt; Hollis Lau; Simon Letarte; Lukas N Mueller; Vagisha Sharma; Olga Vitek; Ning Zhang; Ruedi Aebersold; Julian D Watts
Journal:  BMC Bioinformatics       Date:  2008-12-16       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.